Clinical trial NCT06732739: Combined Effects of Breathing Teach Back Training And Percussion In Patients With Pneumonia
Official title: Combined Effects of Breathing Teach Back Training And Percussion On Pulmonary Functions In Patients With Pneumonia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pneumonia
Keywords: Pneumonia
Percussion
Modified Borg Scale
Lead sponsor: Riphah International University
Sponsor class: OTHER
First posted: 2024-12-13
Enrollment: 30
Sex: ALL
Minimum age (years): 35
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Pneumonia, marked by lung inflammation, leads to symptoms like fever and difficulty breathing, affecting millions globally. It particularly impacts children and the elderly. Lung function is altered, reducing capacities and obstructing airflow. Post-recovery, patients may experience dyspnea due to lingering fluids-deep breathing exercises, using teach-back training, aid rehabilitation. Combining teach-back with chest percussion in physiotherapy aims to enhance respiratory outcomes in pneumonia patients. This will be a randomized clinical trial sample size calculated by epitool sample size calculator which is 30 patients 15 in each group. Regular chest percussion involves a clapping technique in five drainage positions, with assisted suction. Teach-back breathing exercises will also be implemented in this group In Group A, individuals will perform teach-back breathing exercises with chest percussion. In Group B, a similar protocol will be followed without the teach-back breathing exercises. Data analysis, using SPSS version 21, will include the Shapiro-Wilk Test for normality assessment. Descriptive statistics, paired sample t-tests, Wilcoxon signed-rank tests, independent sample t-tests, and Mann-Whitney U tests will be employed to analyze group measurements, changes over time, and differences between groups. This comprehensive approach aims to provide a thorough understanding of the study variables and measurements.


Eligibility criteria: Inclusion Criteria:

* Both genders
* Age 35-45 years
* Diagnosed pneumonia

Exclusion Criteria:

* History of neurological disorders
* History of fractures
* History of other pulmonary complications (15)
* Patients having any chest infection will be excluded

Primary outcomes:
measure: Pulmonary functions test
timeFrame: baseline and fourth week
measure: SF 36
timeFrame: baseline and fourth week
Secondary outcomes:
Other outcomes:
Locations:
city: Lahore
country: Pakistan
facility: Social Security Hospital Lahore
state: Punjab
Study officials:
affiliation: Riphah International University
name: Sidra Afzal, PP-DPT
role: PRINCIPAL_INVESTIGATOR
References:
citation: Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, Wallace JM, Kvale PA, Rosen MJ, Glassroth J, Reichman LB, Stansell JD. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):612-6. doi: 10.1164/ajrccm.162.2.9912058.
citation: Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H; WHO Child Health Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004 Dec;82(12):895-903. Epub 2005 Jan 5.
citation: Hogan DR, Stevens GA, Hosseinpoor AR, Boerma T. Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services. Lancet Glob Health. 2018 Feb;6(2):e152-e168. doi: 10.1016/S2214-109X(17)30472-2. Epub 2017 Dec 13.